SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bharat Immunological And Biological Corporation informs about unaudited financial results

30 Oct 2021 Evaluate

In pursuance of the LODR with Stock Exchange, Bharat Immunological And Biological Corporation has informed that it enclosed the Unaudited quarterly financial results for the quarter and half year ended September 2021 approved by the Board of the Company in its Meeting on 29.10.2021.

The above information is a part of company’s filings submitted to BSE.

Bharat Immunological Share Price

17.20 0.34 (2.02%)
15-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.65
Dr. Reddys Lab 1218.30
Cipla 1226.65
Zydus Lifesciences 936.00
Lupin 2339.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×